drugset / Trial / NCT00738582
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
NaSingle-groupOpen-labelTreatment
Summary
This research is being done to find out if pemetrexed and cisplatin work better when given together with an experimental drug called MORAb-009 in patients with malignant pleural mesothelioma.
Timeline
- Start
- 2008-12-31
- Primary completion
- 2011-06-30
- Completion
- 2014-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amatuximab | Monoclonal antibody | — | Intravenous |
| Background | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | — |